NCT05666960View on ClinicalTrials.gov

R-3750 in Patients With Mild to Moderate Ulcerative Colitis

PHASE1RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 27, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

October 31, 2025

Conditions
Ulcerative Colitis Chronic MildUlcerative Colitis Chronic ModerateUlcerative Colitis ChronicUlcerative Colitis
Interventions
DRUG

R-3750

Probiotic

Trial Locations (3)

33165

RECRUITING

AP Medical Research LLC, Miami

33317

RECRUITING

Edward Jenner Research Group, LLC, Plantation

55902

RECRUITING

Mayo Clinic, Rochester

Sponsors

Collaborators (1)

Mayo Clinic
All Listed Sponsors
collaborator

Mayo Clinic

OTHER

collaborator

University of Colorado, Denver

OTHER

lead

Rise Therapeutics LLC

INDUSTRY

NCT05666960 - R-3750 in Patients With Mild to Moderate Ulcerative Colitis | Biotech Hunter | Biotech Hunter